Elucidating Severity of Waves of COVID-19 in Pakistan

Rabia Zia, Zilwa Mumtaz, Zubia Rahid, Ashaq Ali, Muhammad Zubair Yousaf

Abstract


Background: COVID-19 has radically changed the globe. This virus has a powerful impact on almost every country in the world. The most significant hurdle arises for the overall capacity of a disease control when the number of cases peaks during each wave of the pandemic. There are various waves that have occurred in the preceding period, each of them is characterized by a distinct variant of the virus. For a developing country like Pakistan COVID-19 ruins every sector of the country. There is a proper need for care and protection from this virus as guided by the World Health Organization (WHO). The spread rate is different in every country based on various factors. Two or more factors are required to trigger a high infection rate.

Methods: The data sourced from the National Command and Operations Center (NCOC) was focused on analyzing the data from the four waves of COVID-19 in Pakistan encompassing reported cases, death and testing capacity. Utilizing the SPSS software, a comprehensive examination of these factors was performed.

Results: The data of four waves has been analyzed including reported cases, no. of death, and testing capacity of the country. The data analysis reveals there is a strong correlation between these factors. By the interpretation of the data, it reveals upcoming waves are more dangerous than earlier due to new mutations.

Conclusion: The virus is evolving to become more contagious and infectious in each consecutive wave. Vaccination should be considered compulsory for everyone to win the battle against the virus. Data analysis revealed a correlation between the number of cases and passage of time, showing that the new waves will emerge earlier and have a significant impact on the country.

Keywords: COVID-19; Pakistan; Waves of COVID-19; Vaccination


Full Text:

PDF

References


Chen N, Zhou M, Dong X, Qu J, Gong F, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, (2020); 395(10223): 507-513.

Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta, (2020); 508(5): 254-266.

Abid K, Bari YA, Younas M, Tahir Javaid S, Imran A. Progress of COVID-19 Epidemic in Pakistan. Asia-Pacific Journal of Public Health, (2020); 32(4): 154-156.

Kamran K, Ali A. Challenges and Strategies for Pakistan in the Third Wave of COVID-19: A Mini Review. Frontiers in Public Health, (2021); 9(8): 1-6.

Akhtar S, Khan AA. COVID-19 Pandemic: A Lost Opportunity for International Cooperation? Journal of Security & Strategic Analyses, (2021);7(2):43-64.

Iqbal M, Ma J, Ullah Z, Ahmad N, Ibrahim M, Waqas M, Ahmad M. Identifying lockdown relaxation strategies and policy implications to fight against COVID-19: medical experts perspective from Pakistan. Social Work in Public Health, (2022);37(7):609-30.

Seligmann H, Iggui S, Rachdi M, Vuillerme N, Demongeot J. Inverted covariate effects for first versus mutated second wave Covid-19: high temperature spread biased for young. Biology, (2020);9(8):226.

Imran M, Khan S, Khan S, Uddin A, Khan MS, Ambade P. COVID‐19 situation in Pakistan: A broad overview. Respirology, (2021);26(9):891.

Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study bmj ( 2021);372(3):579.

Yaqinuddin A. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities. Medical Hypotheses, (2020); 144(6): 110049-110049.

Ghosh A, Mukherjee K, Dasgupta Ghosh B, Dutta S. COVID-19 outbreak–The role of worldwide interventions as a preventive measure to fight the pandemic. Available at SSRN 3599808. 2020 May 13.

Deshwal VK. COVID 19: A Comparative Study of Asian, European, American continent. International Journal of Scientific Research and Engineering Development, (2020); 3(2): 436-440.

Bi Q, Wu Y, Mei S, Ye C, Zou X, et al. Epidemiology and transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv,

(2020).

Prata DN, Rodrigues W, Bermejo PH. Temperature significantly changes COVID-19 transmission in (sub) tropical cities of Brazil. Science of the Total Environment. (2020);729:138862.

Xie J, Zhu Y. Association between ambient temperature and COVID-19 infection in 122 cities from China. Science of the Total Environment. (2020);724:138201.

Shannon A, Selisko B, Le NTT, Huchting J, Touret F, et al. Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nature Communications, (2020); 11(1): 1-9.

Cihan P. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World. Applied Soft Computing, (2021); 111107708-107708.

Rocklöv J, Sjödin H. High population densities catalyse the spread of COVID-19. Journal of travel medicine. (2020);27(3):taaa038.

Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health, (2020); 8(4): e488-e496.

Khan S, Ali A, Shi H, Siddique R, Nabi G, Hu J, Wang T, Dong M, Zaman W, Han G. COVID-19: Clinical aspects and therapeutics responses. Saudi Pharmaceutical Journal. (2020);28(8):1004-8.

Yu X, Yang R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza and other Respiratory Viruses, (2020); 14(4): 474-475.

Callaway E. COVID vaccine boosters: the most important questions. Nature, (2021); 596(7871): 178-180.

Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. The Lancet Infectious Diseases, (2021); 1-13.

Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, Mizrahi B, Alroy-Preis S, Ash N, Milo R, Huppert A. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. New England journal of medicine, (2021);385(15):1393-400.

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. International Journal of Infectious Diseases, (2022);114:252-60.




DOI: http://dx.doi.org/10.62940/als.v11i2.1478

Refbacks

  • There are currently no refbacks.